Iterative breakthrough invasive aspergillosis due to TR(34)/L98H azole-resistantAspergillus fumigatusandEmericella sublatain a single hematopoietic stem cell transplant patient

Azole resistance in Aspergillus fumigatus from bronchoalveolar lavage fluid samples of patients with chronic diseases

(2013) Yanan Zhao et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Invasive Pulmonary Aspergillosis Due to Emericella nidulans var. echinulata, Successfully Cured by Voriconazole and Micafungin

(2013) J. Yu et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The impact of azole resistance on aspergillosis guidelines

(2012) Sarah P. Georgiadou et al.   Annals of the New York Academy of Sciences

High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis

(2012) F. Morio et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis

(2012) L. Y. A. Chai et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The correlation among molecular phylogenetics, morphological data, and growth temperature of the genus Emericella, and a new species

(2012) Tetsuhiro Matsuzawa et al.   MYCOSCIENCE

Triazole Fungicides Can Induce Cross-Resistance to Medical Triazoles in Aspergillus fumigatus

(2012) Eveline Snelders et al.   PLoS One

High Prevalence of Azole-Resistant Aspergillus fumigatus in Adults with Cystic Fibrosis Exposed to Itraconazole

(2011) Pierre-Régis Burgel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Rapid Induction of Multiple Resistance Mechanisms in Aspergillus fumigatus during Azole Therapy: a Case Study and Review of the Literature

(2011) Simone M. T. Camps et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in thecyp51AGene

(2011) Shawn R. Lockhart et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Earlier Response Assessment in Invasive Aspergillosis Based on the Kinetics of Serum Aspergillus Galactomannan: Proposal for a New Definition

(2011) S. A. Nouer et al.   CLINICAL INFECTIOUS DISEASES

Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India

(2011) A. Chowdhary et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients

(2010) Olivier Lortholary et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitrosusceptibility testing inAspergillusspecies: an update

(2010) Cornelia Lass-Flörl   Future Microbiology

Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study

(2010) C. Even et al.   HAEMATOLOGICA

Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009

(2010) A. Bueid et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies

(2010) A. Alanio et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Acquired antifungal drug resistance inAspergillus fumigatus:epidemiology and detection

(2010) Susan Julie Howard et al.   MEDICAL MYCOLOGY

Development of Azole Resistance in Aspergillus fumigatus during Azole Therapy Associated with Change in Virulence

(2010) Maiken Cavling Arendrup et al.   PLoS One

Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles

(2009) E. Snelders et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients

(2009) Johan Maertens et al.   CANCER

Azole‐Resistant Central Nervous System Aspergillosis

(2009) Jan W. M. van der Linden et al.   CLINICAL INFECTIOUS DISEASES

Azole-resistance in Aspergillus: Proposed nomenclature and breakpoints

(2009) Paul E. Verweij et al.   DRUG RESISTANCE UPDATES

Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?

(2009) Paul E Verweij et al.   LANCET INFECTIOUS DISEASES

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia–forming moulds

(2008)   CLINICAL MICROBIOLOGY AND INFECTION

Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism

(2008) Eveline Snelders et al.   PLOS MEDICINE

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

(2007) A. Pascual et al.   CLINICAL INFECTIOUS DISEASES